ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Interventional Cardiology

Top Interventional Cardiology Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID LAW MD

Interventional Cardiology

13,603

$695K

859
714 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $52

ALLEN SPITLER MD

Interventional Cardiology

13,003

$657K

893
747 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $52

MUTHU KRISHNAN MD

Interventional Cardiology

11,086

$541K

993
827 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $52

WILLIAM LAFOE MD

Interventional Cardiology

10,411

$454K

751
620 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $52

ROBERT GRANT DO

Interventional Cardiology

10,118

$352K

750
632 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $52

FRANCISCO LAMMOGLIA MD

Interventional Cardiology

9,886

$418K

675
560 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $52

ZUBAIR KHAN MD

Interventional Cardiology

8,793

$387K

832
676 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $52

JAMES CEASER MD

Interventional Cardiology

8,712

$350K

616
496 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $52

KENNETH RETTER MD

Interventional Cardiology

8,518

$471K

663
532 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $52

RICHARD WOLF M.D.

Interventional Cardiology

8,022

$347K

553
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $52

GERALD MANCUSO M.D.

Interventional Cardiology

7,038

$590K

714
663 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 24%

$84
Average prescription price

Avg: $52

ALI ZIAEE MD

Interventional Cardiology

6,708

$422K

548
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $52

DAVID KARDESCH M.D.

Interventional Cardiology

6,498

$418K

776
692 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $52

CLIFFORD TALBERT MD

Interventional Cardiology

6,412

$298K

514
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $52

HARVEY SEROTA M.D.

Interventional Cardiology

6,190

$436K

501
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $52

JEFFREY REESE M.D.

Interventional Cardiology

6,022

$264K

616
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $52

ROBERT KOPITSKY MD

Interventional Cardiology

5,684

$328K

666
613 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $52

WILLIAM CRAIG M.D.

Interventional Cardiology

5,663

$227K

418
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $52

SUNDEEP DAS M.D.

Interventional Cardiology

5,589

$434K

513
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $52

MICHAEL GOLDMEIER M.D.

Interventional Cardiology

5,487

$316K

622
567 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $52

BASSEM MIKHAIL MD

Interventional Cardiology

5,103

$173K

415
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 24%

$34
Average prescription price

Avg: $52

BASSAM ROUKOZ M.D.

Interventional Cardiology

5,002

$230K

541
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $52

MARK TABER M.D.

Interventional Cardiology

4,813

$260K

519
469 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $52

JAMES HOFF M.D.

Interventional Cardiology

4,563

$214K

428
363 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $52

PHILLIP APPRILL M.D.

Interventional Cardiology

4,391

$220K

481
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank